Review
Incorporating Alcohol Pharmacotherapies Into Medical Practice
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2009. Report No.: (SMA) 09-4380.
- PMID: 22514855
- Bookshelf ID: NBK64041
Item in Clipboard
Review
Incorporating Alcohol Pharmacotherapies Into Medical Practice
Excerpt
This TIP, Incorporating Alcohol Pharmacotherapies Into Medical Practice, revises and expands on TIP 28, Naltrexone and Alcoholism Treatment, and includes discussion of the other medications currently approved for treating alcohol use disorders (AUDs). It provides the basic information, evidence- and consensus-based guidelines, tools, and resources necessary to help healthcare practitioners treat patients with AUDs.
Sections
- Consensus Panel
- Expert Advisory Board
- What Is a TIP?
- Foreword
- Chapter 1—Introduction
- Chapter 2—Acamprosate
- Chapter 3—Disulfiram
- Chapter 4—Oral Naltrexone
- Chapter 5—Extended-Release Injectable Naltrexone
- Chapter 6—Patient Management
- Appendix A—Bibliography
-
Appendix B—NIAAA's
A Pocket Guide for Alcohol Screening and Brief Intervention -
Appendix C—Excerpts From Quick Guide for Clinicians Based on TIP 45,
Detoxification and Substance Abuse Treatment -
Appendix D—Excerpts From Quick Guide for Clinicians Based on TIP 24,
A Guide to Substance Abuse Services for Primary Care Clinicians - Appendix E—Resource Panel
- Appendix F—Field Reviewers
- Appendix G—Acknowledgments
Publication types
Grants and funding
This publication was produced under the Knowledge Application Program, contract number 270-04-7049, a Joint Venture of The CDM Group, Inc., and JBS International, Inc., for the Center for Substance Abuse Treatment (CSAT), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS). Christina Currier served as the CSAT Government Project Officer.
LinkOut - more resources
Full Text Sources
